Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

The retired tennis pro explained that she’s trying to combat the stigma associated with weight loss drugs after losing 31 ...

Serena Williams revealed she uses GLP-1 medication to aid weight loss after motherhood. This highlights a shift towards combining medicine with lifestyle for obesity management.

米製薬大手イーライリリーが 8月上旬に発表した初期試験の結果 ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

2025年8月15日、米食品医薬品局（FDA）は、GLP-1受容体作動薬セマグルチド（商品名ウゴービ）をMASH（代謝機能障害関連脂肪肝炎）の適応で迅速承認（acceleratedapproval）した（外部リンク）。治療選択肢が限られるMASHに適 ...